GO:0035914 skeletal muscle cell differentiation: Myogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035914 describes the biological process by which a relatively unspecialized cell acquires the specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
• Skeletal muscle cell differentiation is driven by the sequential activation of myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6) and downstream structural genes such as MYH, ACTA1, and CKM.
• Single-cell RNA sequencing has resolved distinct myogenic and non-myogenic cell populations in skeletal muscle, revealing heterogeneity in differentiation trajectories.
• Differentiation can be quantified in vitro using live-cell imaging and eccentricity measures, providing a robust readout for myoblast fusion and myotube formation.
• Signaling pathways including PI3K/Akt/mTOR and pannexin-mediated communication regulate the balance between myoblast proliferation and differentiation.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes implicated in skeletal muscle cell differentiation and related diseases.
Description
Skeletal muscle cell differentiation (GO:0035914) is the biological process in which a relatively unspecialized cell acquires the specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. This process is central to embryonic myogenesis, postnatal muscle growth, and adult muscle regeneration, and it is orchestrated by a conserved network of transcription factors and signaling pathways. Understanding the molecular control of skeletal muscle cell differentiation is essential for developmental biology, regenerative medicine, and the study of muscle-wasting diseases. Recent advances in single-cell RNA sequencing have provided unprecedented resolution of the cellular heterogeneity and differentiation trajectories within skeletal muscle. In parallel, in vitro models of myogenesis have been refined to optimize cell fate determination and to quantify differentiation using live-cell imaging and morphological parameters. These tools allow researchers to dissect the contribution of individual genes and pathways to skeletal muscle cell differentiation. The process is regulated by myogenic regulatory factors, non-myogenic resident cells, and signaling cascades such as PI3K/Akt/mTOR and pannexin-mediated communication. Disruption of these regulatory mechanisms contributes to impaired muscle regeneration and disease. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:0035914, its key genes, regulatory mechanisms, disease relevance, and experimental methods.
skeletal muscle cell differentiation At A Glance
| GO ID | GO:0035914 |
|---|---|
| GO term | skeletal muscle cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Definition | The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. |
| Major function | Generation of specialized skeletal muscle cells from uncommitted or myogenic precursor cells |
| Related processes | Myoblast fusion, myotube formation, muscle regeneration, myogenesis |
| Key regulators | MYOD1, MYF5, MYOG, MYF6, MEF2 family, PI3K/Akt/mTOR signaling |
| Research relevance | Developmental biology, regenerative medicine, muscle-wasting diseases, cultivated meat production |
What Is GO:0035914?
GO:0035914 (skeletal muscle cell differentiation) is defined as the process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. In practice, this encompasses the commitment of myogenic precursors, their exit from the cell cycle, expression of muscle-specific structural and contractile proteins, and fusion into multinucleated myotubes or maturation into functional myofibers. The term is a biological process annotation and does not include the specification of muscle progenitor identity per se, but rather the differentiation steps that generate the specialized skeletal muscle cell phenotype.
Why Is skeletal muscle cell differentiation Important in Cell Biology?
Skeletal muscle cell differentiation is fundamental to the formation, maintenance, and repair of skeletal muscle, the largest tissue by mass in the human body. Defects in this process underlie congenital myopathies, muscular dystrophies, and age-related sarcopenia, and they impair regeneration after injury. In addition, understanding differentiation is critical for emerging applications such as cultivated meat production, where optimized cell fate determination directly affects product quality and scalability. The process also serves as a paradigm for studying cell fate decisions, since it involves coordinated changes in proliferation, migration, and fusion that are regulated by both cell-intrinsic factors and the tissue microenvironment. Consequently, research on GO:0035914 informs therapeutic strategies for muscle disorders and advances tissue engineering.
• Skeletal muscle cell differentiation is required for embryonic muscle development and postnatal muscle growth.
• It is essential for adult muscle regeneration after injury, relying on satellite cell activation and differentiation.
• Impaired differentiation contributes to muscular dystrophies and congenital myopathies.
• Dysregulated differentiation is implicated in muscle wasting and sarcopenia.
• The process is a target for cultivated meat production, where optimized differentiation improves yield and texture.
• Single-cell RNA sequencing has revealed distinct myogenic and non-myogenic cell populations that influence differentiation.
• Quantitative imaging of myoblast differentiation enables high-throughput screening of regulatory genes.
• Pannexin-mediated signaling modulates myoblast proliferation and differentiation, linking membrane channels to myogenesis.
• PI3K/Akt/mTOR signaling is a key regulator of skeletal muscle cell growth and differentiation.
• Substrate coating and culture conditions can enhance skeletal muscle fiber type transition in vitro.
What Happens During skeletal muscle cell differentiation?
Commitment and Myogenic Determination
In simple terms: Unspecialized cells first decide to become muscle cells.
The earliest step in skeletal muscle cell differentiation involves the commitment of multipotent mesodermal precursors to the myogenic lineage. This step is marked by the expression of myogenic determination factors such as MYOD1 and MYF5, which initiate the muscle-specific transcriptional program. Single-cell RNA sequencing studies have identified distinct myogenic and non-myogenic cell populations in developing and adult skeletal muscle, revealing that commitment is influenced by both intrinsic factors and signals from the surrounding niche.
Myoblast Proliferation and Cell Cycle Exit
In simple terms: Muscle precursor cells multiply and then stop dividing to specialize.
Once committed, myoblasts proliferate to expand the precursor pool. Subsequent cell cycle exit is a prerequisite for terminal differentiation and is regulated by myogenic factors and signaling pathways. Pannexin channels have been shown to regulate myoblast proliferation and differentiation, indicating that membrane communication contributes to the balance between these states. The PI3K/Akt/mTOR pathway also plays a central role in coordinating growth signals with differentiation.
Myocyte Fusion and Myotube Formation
In simple terms: Individual muscle cells fuse together to form long, multinucleated fibers.
Terminally differentiating myocytes express muscle-specific structural proteins and fuse to form multinucleated myotubes. This fusion process is a hallmark of skeletal muscle cell differentiation and can be quantified using live-cell imaging and eccentricity measures, which capture changes in cell shape associated with elongation and fusion. The expression of myogenin (MYOG) and MYF6 drives the late differentiation program, including the activation of genes encoding contractile proteins.
Maturation and Fiber Type Specification
In simple terms: New muscle fibers mature and adopt specific functional types.
After fusion, myotubes mature into functional myofibers with specialized contractile and metabolic properties. Fiber type specification is influenced by extrinsic factors such as substrate coating, which can enhance skeletal muscle fiber type transition in myoblast culture. Maturation involves the coordinated expression of myosin heavy chain isoforms, metabolic enzymes, and structural proteins that define the skeletal muscle cell phenotype.
Regulation by Non-Myogenic Cells and Microenvironment
In simple terms: Other cells around the muscle help control how muscle cells develop.
Skeletal muscle contains non-myogenic resident cells, including distinct mesenchymal populations, that modulate myogenesis through secreted factors and cell-cell interactions. These non-myogenic cells can influence differentiation efficiency and are increasingly recognized as important regulators of muscle homeostasis and repair. Optimizing culture conditions to account for these interactions can improve in vitro differentiation outcomes.
Key Genes Involved in GO:0035914 skeletal muscle cell differentiation
The following genes and proteins are central to skeletal muscle cell differentiation, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Myogenic determination factor; initiates muscle-specific transcription | Core regulator of differentiation; knockout blocks myogenesis |
| MYF5 | Myogenic determination factor; acts redundantly with MYOD1 | Essential for early myogenic commitment |
| MYOG | Myogenin; drives terminal differentiation and fusion | Marker of late differentiation; required for myotube formation |
| MYF6 | Myogenic factor 6; promotes maturation of myotubes | Regulates late differentiation genes |
| MEF2C | MADS-box transcription factor; cooperates with myogenic factors | Enhances muscle-specific gene expression |
| MYH1 | Myosin heavy chain; contractile protein | Marker of mature skeletal muscle fibers |
| ACTA1 | Alpha-actin; structural component of sarcomere | Expressed during myotube formation |
| CKM | Creatine kinase, muscle; energy metabolism | Marker of differentiated muscle cells |
| FHL3 | Four and a half LIM domain protein 3; regulates growth via PI3K/Akt/mTOR | Modulates skeletal muscle cell growth and differentiation |
| PANX1 | Pannexin 1; membrane channel | Regulates myoblast proliferation and differentiation |
| PANX3 | Pannexin 3; membrane channel | Influences myoblast differentiation |
| PAX7 | Paired box 7; satellite cell marker | Maintains muscle stem cell pool; required for regeneration |
| PAX3 | Paired box 3; early myogenic marker | Specifies myogenic progenitors |
| CDK1 | Cyclin-dependent kinase 1; cell cycle regulator | Controls proliferation exit before differentiation |
| AKT1 | Serine/threonine kinase; PI3K/Akt/mTOR pathway | Promotes myoblast differentiation and hypertrophy |
| MTOR | Mechanistic target of rapamycin; growth regulator | Coordinates protein synthesis with differentiation |
| IGF1 | Insulin-like growth factor 1; growth factor | Stimulates myoblast differentiation via PI3K/Akt |
| DES | Desmin; intermediate filament protein | Structural marker of differentiated muscle |
How Is skeletal muscle cell differentiation Regulated?
Skeletal muscle cell differentiation is regulated by a multilayered network that includes myogenic transcription factors, signaling pathways, and cell-cell communication. The PI3K/Akt/mTOR pathway is a central regulator of muscle cell growth and differentiation, integrating growth factor signals such as IGF1 to promote protein synthesis and myogenic gene expression. Pannexin channels (PANX1 and PANX3) modulate myoblast proliferation and differentiation, linking membrane permeability and ATP release to the differentiation program. Non-myogenic resident mesenchymal cells in skeletal muscle can also influence differentiation through paracrine signaling, as revealed by single-cell transcriptomic analyses. In vitro, differentiation efficiency can be optimized by adjusting cell fate determination protocols and substrate coatings, which affect fiber type transition and maturation. These regulatory mechanisms ensure that differentiation is coordinated with nutrient availability, energy status, and tissue demands.
skeletal muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYOD1 | Congenital myopathy with impaired myogenesis | Knockout and point-mutation cell models |
| MYOG | Myotube formation defects | Knockout and overexpression models |
| FHL3 | Muscle growth dysregulation via PI3K/Akt/mTOR | Knockout and overexpression in bovine skeletal muscle cells |
| PANX1 | Altered myoblast proliferation and differentiation | Knockout and pharmacological inhibition |
| PAX7 | Satellite cell dysfunction in muscle regeneration | Knock-in reporter and lineage tracing |
Muscular Dystrophies and Congenital Myopathies
Defects in skeletal muscle cell differentiation contribute to congenital myopathies and muscular dystrophies, where impaired myoblast fusion or defective myofiber maturation leads to muscle weakness and degeneration. Mutations in genes encoding myogenic regulatory factors or structural proteins can disrupt the differentiation program, and research using patient-derived cells and animal models continues to elucidate these mechanisms.
Muscle Wasting and Sarcopenia
Age-related sarcopenia and cachexia involve dysregulated muscle homeostasis, including impaired regenerative capacity of satellite cells and altered differentiation potential. Single-cell studies have highlighted changes in myogenic and non-myogenic cell populations that may contribute to impaired differentiation in aged or diseased muscle.
Rhabdomyosarcoma and Aberrant Differentiation
Rhabdomyosarcoma is a pediatric cancer that arises from cells with impaired myogenic differentiation. Although the exact mechanisms are complex, the failure to complete terminal differentiation is a hallmark of this disease, and myogenic regulatory factors are often dysregulated. Understanding normal skeletal muscle cell differentiation provides a framework for studying how differentiation arrest contributes to tumorigenesis.
Cultivated Meat and Tissue Engineering
In the context of cultivated meat production, optimizing skeletal muscle cell differentiation is essential for generating edible muscle tissue with appropriate texture and nutritional properties. Substrate coating and culture conditions can enhance fiber type transition and differentiation efficiency, linking basic differentiation biology to applied biotechnology.
From skeletal muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for myoblast differentiation? | CRISPR knockout in C2C12 or primary myoblasts |
| Does a specific mutation affect myogenic factor function? | Point-mutation knock-in in myogenic cells |
| Does overexpression of a gene enhance differentiation? | Overexpression cell model with inducible promoter |
| Where and when is a protein expressed during differentiation? | Tagged knock-in with fluorescent reporter |
| How do non-myogenic cells influence differentiation? | Co-culture with sorted mesenchymal populations |
| Can substrate coating alter fiber type transition? | In vitro myoblast culture on modified substrates |
How to Study the skeletal muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA sequencing | Cell heterogeneity and differentiation trajectories | Identifying myogenic and non-myogenic populations |
| Live-cell imaging with eccentricity | Cell shape changes and fusion | Quantifying myoblast differentiation |
| Immunostaining for MYH | Myotube formation and fusion index | Assessing differentiation efficiency |
| RNA-seq | Transcriptional changes during differentiation | Validating gene expression programs |
| Proteomics | Protein abundance and modifications | Identifying differentiation markers |
| CRISPR knockout screening | Gene requirement for differentiation | Discovering novel regulators |
| Substrate coating assays | Fiber type transition | Optimizing culture conditions |
Single-Cell RNA Sequencing
Single-cell RNA sequencing enables the dissection of cellular heterogeneity during skeletal muscle development and regeneration, revealing distinct myogenic and non-myogenic cell populations and their differentiation trajectories. This method is particularly powerful for identifying rare progenitor states and for comparing differentiation across conditions.
Live-Cell Imaging and Morphological Quantification
Live-cell imaging combined with eccentricity measures provides a quantitative readout of myoblast differentiation, including changes in cell shape, elongation, and fusion index. This approach allows real-time monitoring of differentiation dynamics and can be adapted for high-throughput screening.
Transcriptomic and Proteomic Profiling
Bulk RNA sequencing and proteomics can quantify the expression of myogenic regulatory factors and structural proteins during differentiation. These methods are useful for validating the effects of genetic perturbations and for identifying novel regulators of skeletal muscle cell differentiation.
In Vitro Differentiation Assays
Standard in vitro assays using C2C12 myoblasts or primary satellite cells involve serum withdrawal to induce differentiation, followed by immunostaining for myosin heavy chain and fusion index calculation. Optimization of cell fate determination protocols and substrate coatings can improve differentiation efficiency and fiber type transition.
How CRISPR Can Be Used to Study GO:0035914 skeletal muscle cell differentiation
Knockout
CRISPR knockout of candidate genes in myoblast cell lines or primary cells allows researchers to test whether a gene is required for skeletal muscle cell differentiation. For example, knockout of MYOD1 or MYOG blocks differentiation, validating their essential roles. Knockout models are also used to study non-myogenic regulators such as PANX1 and FHL3.
Point Mutation
Point-mutation knock-in can model disease-associated variants in genes involved in differentiation. This approach is useful for dissecting the functional impact of specific amino acid changes in myogenic transcription factors or structural proteins, and for understanding how mutations contribute to congenital myopathies.
Knock-in
Knock-in of reporter tags or fluorescent proteins enables real-time tracking of differentiation markers. For example, tagging MYOG or MYH with a fluorescent reporter allows live-cell imaging of myotube formation and quantification of differentiation dynamics.
Overexpression
Overexpression of pro-differentiation genes such as MYOD1 or IGF1 can drive or enhance skeletal muscle cell differentiation. Overexpression models are valuable for studying gain-of-function effects and for biotechnological applications such as cultivated meat production.
How EDITGENE Supports skeletal muscle cell differentiation Research
Researchers studying skeletal muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to support such investigations, from knockout and point-mutation cell models to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for skeletal muscle cell differentiation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MYOD1 Knockout HEK293 Cell Line | EDJ-KQ1334 | Human | 4654 | Details Get a Quote |
| MYLK2 Knockout HEK293 Cell Line | EDJ-KQ1435 | Human | 85366 | Details Get a Quote |
| MYOG Knockout HEK293 Cell Line | EDJ-KQ1968 | Human | 4656 | Details Get a Quote |
| MYF5 Knockout HEK293 Cell Line | EDJ-KQ3025 | Human | 4617 | Details Get a Quote |
| MYF6 Knockout HEK293 Cell Line | EDJ-KQ3614 | Human | 4618 | Details Get a Quote |
| KLHL41 Knockout HEK293 Cell Line | EDJ-KQ7007 | Human | 10324 | Details Get a Quote |
| EGR2 Knockout HEK293 Cell Line | EDJ-KQ17870 | Human | 1959 | Details Get a Quote |
| MYLK2 Knockout HCT 116 Cell Line | EDJ-KQ20981 | Human | 85366 | Details Get a Quote |
| MYLK2 Knockout HeLa Cell Line | EDJ-KQ20982 | Human | 85366 | Details Get a Quote |
| EGR2 Knockout HeLa Cell Line | EDJ-KQ53146 | Human | 1959 | Details Get a Quote |
| MYF5 Knockout HeLa Cell Line | EDJ-KQ53935 | Human | 4617 | Details Get a Quote |
| MYF6 Knockout HeLa Cell Line | EDJ-KQ53936 | Human | 4618 | Details Get a Quote |
| MYOD1 Knockout HeLa Cell Line | EDJ-KQ53954 | Human | 4654 | Details Get a Quote |
| MYOG Knockout HeLa Cell Line | EDJ-KQ53955 | Human | 4656 | Details Get a Quote |
| KLHL41 Knockout HeLa Cell Line | EDJ-KQ55378 | Human | 10324 | Details Get a Quote |
Displaying Records 1 To 15 Of 28 Records
Frequently Asked Questions About skeletal muscle cell differentiation
What is GO:0035914?
GO:0035914 is the Gene Ontology term for skeletal muscle cell differentiation, the process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
What genes are involved in skeletal muscle cell differentiation?
Key genes include MYOD1, MYF5, MYOG, MYF6, MEF2C, MYH1, ACTA1, CKM, PAX7, and signaling regulators such as FHL3, PANX1, and AKT1.
How is skeletal muscle cell differentiation regulated?
It is regulated by myogenic transcription factors, PI3K/Akt/mTOR signaling, pannexin channels, and interactions with non-myogenic resident cells.
What are the stages of skeletal muscle cell differentiation?
The main stages are commitment, myoblast proliferation and cell cycle exit, myocyte fusion, and maturation into myofibers.
How can I study skeletal muscle cell differentiation in the lab?
Common methods include in vitro differentiation assays with C2C12 cells, live-cell imaging, single-cell RNA sequencing, and CRISPR-based perturbation.
What diseases are linked to defective skeletal muscle cell differentiation?
Muscular dystrophies, congenital myopathies, sarcopenia, and rhabdomyosarcoma are associated with impaired differentiation.
Can CRISPR be used to study skeletal muscle cell differentiation?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to test gene function in myogenic cells.
What is the role of MYOD1 in skeletal muscle cell differentiation?
MYOD1 is a myogenic determination factor that initiates the muscle-specific transcriptional program and is essential for differentiation.
How do non-myogenic cells affect skeletal muscle differentiation?
Non-myogenic resident mesenchymal cells can modulate differentiation through secreted factors and cell-cell interactions.
What is the relevance of skeletal muscle cell differentiation to cultivated meat?
Optimizing differentiation is critical for producing cultivated muscle tissue with appropriate texture and yield.
Conclusion
GO:0035914 skeletal muscle cell differentiation is a fundamental biological process that underpins muscle development, regeneration, and homeostasis. Its regulation by myogenic transcription factors, signaling pathways, and non-myogenic cells is increasingly well understood through single-cell and imaging technologies. Dysregulation of this process contributes to a range of muscle diseases and is a key consideration in emerging biotechnologies such as cultivated meat. CRISPR-based models offer powerful tools to dissect the genetic control of differentiation and to translate these insights into therapeutic and industrial applications.
References
- 1. Cai C et al.. 2023. Single-cell RNA sequencing in skeletal muscle developmental biology.. Biomed Pharmacother 162:114631 PMID: 37003036
- 2. Chal J et al.. 2017. Making muscle: skeletal myogenesis in vivo and in vitro.. Development 144(12):2104-2122 PMID: 28634270
- 3. Leinroth AP et al.. 2022. Identification of distinct non-myogenic skeletal-muscle-resident mesenchymal cell populations.. Cell Rep 39(6):110785 PMID: 35545045
- 4. Melzener L et al.. 2024. Optimisation of cell fate determination for cultivated muscle differentiation.. Commun Biol 7(1):1493 PMID: 39532984
- 5. Arneson-Wissink PC et al.. 2022. Quantification of Muscle Stem Cell Differentiation Using Live-Cell Imaging and Eccentricity Measures.. Methods Mol Biol 2429:455-471 PMID: 35507181
- 6. Langlois S et al.. 2017. Regulation of Skeletal Muscle Myoblast Differentiation and Proliferation by Pannexins.. Adv Exp Med Biol 925:57-73 PMID: 27518505
- 7. Zhou X et al.. 2024. FHL3 gene regulates bovine skeletal muscle cell growth through the PI3K/Akt/mTOR signaling pathway.. Comp Biochem Physiol Part D Genomics Proteomics 52:101356 PMID: 39549419
- 8. Riskawati YK et al.. 2025. Enhancing Skeletal Muscle Fiber Type Transition Through Substrate Coating Alteration in Myoblast Cell Culture.. Int J Mol Sci 26(12) PMID: 40565101
